These are certainly strange times, and the need to connect with others is more important than ever, especially for men who are affected by prostate cancer and their loved ones. While living with restrictions related to COVID, these men and women continue to deal with important treatment decisions or management of side effects associated with prostate cancer treatment. Us TOO and AnCan are proud to offer Prostate Cancer Connections, a series of educational and interactive webinars which will bring people together virtually and safely to access empowering, decision-making information and personal connections in a time of social distancing. For the third of our three webinars, we offer a discussion on Imaging and Prostate Cancer.

Dr. Brian T. Helfand is the Richard Melman and Ron Chez Family Chair and Chief of Urology at NorthShore University HealthSystem in Evanston, Illinois. He is an Associate Professor at the University of Chicago and former Adjunct Professor at Northwestern University. He holds MD and PhD degrees, and is head of clinical and research programs focused on prostate cancer. Dr. Helfand has authored more than 200 peer reviewed manuscripts. Currently, his interests are devoted towards using novel imaging techniques and biomarkers,

including genetics, to help guide clinical decision making for men with newly diagnosed and advanced prostate cancer.